Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Perinatal risk factors interacting with catechol O-methyltransferase and the serotonin transporter gene predict ASD symptoms in children with ADHD.
Nijmeijer JS, Hartman CA, Rommelse NN, Altink ME, Buschgens CJ, Fliers EA, Franke B, Minderaa RB, Ormel J, Sergeant JA, Verhulst FC, Buitelaar JK, Hoekstra PJ. Nijmeijer JS, et al. J Child Psychol Psychiatry. 2010 Nov;51(11):1242-50. doi: 10.1111/j.1469-7610.2010.02277.x. Epub 2010 Sep 24. J Child Psychol Psychiatry. 2010. PMID: 20868372 Free PMC article.
How to use the ADI-R for classifying autism spectrum disorders? Psychometric properties of criteria from the literature in 1,204 Dutch children.
de Bildt A, Oosterling IJ, van Lang ND, Kuijper S, Dekker V, Sytema S, Oerlemans AM, van Steijn DJ, Visser JC, Rommelse NN, Minderaa RB, van Engeland H, van der Gaag RJ, Buitelaar JK, de Jonge MV. de Bildt A, et al. Among authors: minderaa rb. J Autism Dev Disord. 2013 Oct;43(10):2280-94. doi: 10.1007/s10803-013-1783-1. J Autism Dev Disord. 2013. PMID: 23397166
Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study.
Harfterkamp M, Buitelaar JK, Minderaa RB, van de Loo-Neus G, van der Gaag RJ, Hoekstra PJ. Harfterkamp M, et al. Among authors: minderaa rb. J Child Adolesc Psychopharmacol. 2013 Apr;23(3):194-9. doi: 10.1089/cap.2012.0012. Epub 2013 Apr 11. J Child Adolesc Psychopharmacol. 2013. PMID: 23578015 Clinical Trial.
Atomoxetine in autism spectrum disorder: no effects on social functioning; some beneficial effects on stereotyped behaviors, inappropriate speech, and fear of change.
Harfterkamp M, Buitelaar JK, Minderaa RB, van de Loo-Neus G, van der Gaag RJ, Hoekstra PJ. Harfterkamp M, et al. Among authors: minderaa rb. J Child Adolesc Psychopharmacol. 2014 Nov;24(9):481-5. doi: 10.1089/cap.2014.0026. Epub 2014 Nov 4. J Child Adolesc Psychopharmacol. 2014. PMID: 25369243 Clinical Trial.
A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.
Harfterkamp M, van de Loo-Neus G, Minderaa RB, van der Gaag RJ, Escobar R, Schacht A, Pamulapati S, Buitelaar JK, Hoekstra PJ. Harfterkamp M, et al. Among authors: minderaa rb. J Am Acad Child Adolesc Psychiatry. 2012 Jul;51(7):733-41. doi: 10.1016/j.jaac.2012.04.011. Epub 2012 May 25. J Am Acad Child Adolesc Psychiatry. 2012. PMID: 22721596 Clinical Trial.
155 results